Recombinant Saccharomyces cerevisiae Uncharacterized protein YGL041C-B (YGL041C-B)

Shipped with Ice Packs
In Stock

Description

Production and Purification

Recombinant YGL041C-B is produced in heterologous expression systems, with protocols optimized for high purity:

ParameterSpecification
Host SystemsE. coli, yeast, baculovirus, or mammalian cells
Purity≥85% (verified by SDS-PAGE)
TaggingHis-tag or untagged versions available
StorageTris-based buffer with 50% glycerol; stable at -20°C or -80°C

Cell-free expression systems have also been employed to produce tag-free variants .

Functional Insights and Interactions

Despite its uncharacterized status, interactome studies suggest potential roles:

Protein–RNA Interactions

YGL041C-B exhibits predicted interactions with multiple RNA molecules, including:

RNA PartnerGeneInteraction ScoreFunction of RNA Partner
NSR1YGR159C13.8Nucleolin homolog; ribosome biogenesis
NOP1YDL014W13.36rRNA methylation and ribosome assembly
MDJ1YFL016C12.25Mitochondrial chaperone

These interactions, detected via catRAPID predictions, imply possible involvement in RNA metabolism or ribosomal processes .

Genetic Context

  • Flanked by genes YGL041C (uncharacterized) and YGL042W (ribosomal protein) .

  • No Gene Ontology (GO) terms assigned, reflecting its unknown biological role .

Research Applications

Recombinant YGL041C-B is primarily utilized in:

  1. Antibody Production: Rabbit polyclonal antibodies (IgG) generated against this protein are validated for ELISA and Western blotting .

  2. Protein Interaction Studies: Used as bait or prey in yeast two-hybrid screens .

  3. Structural Biology: Serves as a substrate for crystallography or NMR due to its small size .

Unresolved Questions and Future Directions

Key knowledge gaps include:

  • Functional Role: Whether YGL041C-B participates in stress responses, RNA processing, or novel pathways.

  • Post-Translational Modifications: Phosphorylation or ubiquitination sites remain unverified .

  • Evolutionary Conservation: Homologs in other fungi (e.g., Candida spp.) could clarify its significance .

Product Specs

Form
Lyophilized powder
Note: We will prioritize shipping the format currently in stock. However, if you have specific format requirements, please indicate them during order placement, and we will prepare the product accordingly.
Lead Time
Delivery time may vary depending on the purchasing method and location. Please consult your local distributors for specific delivery estimates.
Note: All our proteins are shipped with standard blue ice packs. If you require dry ice shipment, please notify us in advance. Additional fees will apply.
Notes
Repeated freeze-thaw cycles are not recommended. Store working aliquots at 4°C for up to one week.
Reconstitution
We recommend briefly centrifuging the vial before opening to ensure the contents settle at the bottom. Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%. Customers can use this as a reference.
Shelf Life
Shelf life is influenced by various factors including storage conditions, buffer ingredients, temperature, and protein stability.
Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is necessary for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type will be determined during the manufacturing process.
Tag type will be determined during production. If you have a specific tag type requirement, please inform us, and we will prioritize developing the specified tag.
Synonyms
YGL041C-B; Uncharacterized protein YGL041C-B
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-60
Protein Length
full length protein
Species
Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)
Target Names
YGL041C-B
Target Protein Sequence
MFDSSIERVTLELCFHITLSIMCGCSIYFLLLVFILTFYSSVLLHLKLYFFSSDRAIFNA
Uniprot No.

Target Background

Database Links
Subcellular Location
Membrane; Single-pass membrane protein.

Q&A

What is YGL041C-B and why is it classified as uncharacterized?

YGL041C-B is a protein-coding gene in Saccharomyces cerevisiae located on chromosome VII. The protein remains classified as uncharacterized because its specific biological function, biochemical activities, and structural characteristics have not been fully elucidated through experimental validation. While genomic sequencing has identified its presence, functional studies have not yet definitively determined its role in yeast cellular processes. Methodologically, researchers should approach uncharacterized proteins by first conducting comparative sequence analyses against characterized proteins across species, followed by targeted gene deletion or overexpression experiments to observe resulting phenotypes .

What basic experimental approaches should I consider when beginning research on YGL041C-B?

When initiating research on an uncharacterized protein like YGL041C-B, employ a systematic approach beginning with bioinformatic analyses to identify potential functional domains and homology to characterized proteins. Follow this with expression analysis to determine when and where the protein is expressed. Basic experimental techniques should include:

  • Genomic tagging (GFP/FLAG) for localization studies

  • Gene knockout experiments to observe phenotypic effects

  • Protein expression and purification for biochemical characterization

  • Yeast two-hybrid screening to identify interaction partners

  • RT-PCR and RNA-seq for expression pattern analysis

For each approach, establish appropriate experimental controls and ensure consistency in strain background and growth conditions to maintain reproducibility .

How should I design my first experiment to study the intracellular localization of YGL041C-B?

To study the intracellular localization of YGL041C-B, design an experiment using fluorescent protein tagging with the following methodological considerations:

Experimental ComponentDescriptionRationale
Independent VariableC-terminal vs. N-terminal GFP taggingTesting optimal tagging position that doesn't disrupt protein function
Dependent VariableSubcellular localization patternPrimary outcome measurement
Controlled Variables1. Yeast strain background
2. Growth medium composition
3. Cell growth phase at observation
Minimize experimental variability
Standard of ComparisonUntagged wild-type strainEstablish baseline autofluorescence
ReplicatesMinimum 3 biological replicatesEnsure statistical validity

Include verification of proper integration by PCR and Western blotting to confirm expression of the full-length fusion protein. Observe cells under different growth conditions and stress treatments to determine if localization is dynamic. Compare results with predictive algorithms for subcellular localization to validate your findings .

How can I determine if introgression events have affected the evolutionary history of YGL041C-B in different Saccharomyces strains?

Introgression events, where genetic material from one species is incorporated into another through hybridization, can significantly impact protein evolution. To investigate if YGL041C-B has been subject to introgression:

  • Sequence YGL041C-B from multiple Saccharomyces strains and species

  • Perform phylogenetic analysis to identify incongruent evolutionary patterns

  • Apply comparative genomic hybridization using multi-species microarrays

  • Conduct selective sequence analysis of flanking regions to identify transition points

Evidence of introgression would appear as unexpected phylogenetic clustering or hybridization patterns. For example, if YGL041C-B from certain S. cerevisiae strains shows higher sequence similarity to S. paradoxus than to other S. cerevisiae strains, this could indicate introgression, similar to patterns observed in other yeast genes like CCA1, DST1, and UIP5 .

When analyzing sequence data, pay particular attention to:

  • Divergent nucleotide patterns across the gene length

  • Abrupt changes in sequence similarity at specific genomic coordinates

  • Statistical analysis of sequence divergence using methods like the Hudson-Kreitman-Aguadé test

These approaches can reveal whether YGL041C-B has experienced complex evolutionary dynamics beyond simple vertical inheritance .

What are the most robust approaches for determining the function of YGL041C-B through multi-omics integration?

Determining the function of uncharacterized proteins like YGL041C-B requires integrated multi-omics approaches. A comprehensive strategy should include:

  • Transcriptomic profiling: Perform RNA-seq under various conditions to identify co-regulated genes

  • Proteomics: Use IP-MS/MS to identify interaction partners and post-translational modifications

  • Metabolomics: Analyze metabolic changes in knockout/overexpression strains

  • Phenomics: Conduct high-throughput phenotypic assays under diverse stress conditions

Integration methodology:

  • Apply network analysis to identify functional modules containing YGL041C-B

  • Use Bayesian integration of multiple data types to predict function

  • Implement supervised machine learning approaches trained on proteins with known functions

The strength of this approach lies in triangulating evidence across multiple biological levels rather than relying on a single experimental approach. When contradictions appear between different omics layers, these can often highlight regulatory mechanisms or conditional functionality of the protein .

How can I address contradictory results between computational predictions and experimental observations for YGL041C-B?

When faced with contradictions between computational predictions and experimental results for YGL041C-B, apply a systematic troubleshooting approach:

  • Evaluate prediction algorithm limitations:

    • Review the training datasets used by prediction algorithms

    • Assess algorithm performance on similar proteins

    • Consider if YGL041C-B contains unusual features not well-represented in training data

  • Re-examine experimental design:

    • Analyze potential confounding factors in experimental setup

    • Evaluate if experimental conditions match those assumed in computational models

    • Consider whether protein tags or fusion constructs affect native function

  • Reconciliation strategies:

    • Design experiments specifically targeting the contradictory aspects

    • Use alternative computational approaches with different underlying assumptions

    • Consider if the contradiction reveals novel biological insights

  • Contextual analysis:

    • Determine if contradictions are condition-dependent or strain-specific

    • Investigate if post-translational modifications explain functional discrepancies

Contradictions often represent valuable research opportunities rather than experimental failures, as they may highlight novel biological mechanisms or context-dependent protein functions .

What experimental controls are critical when characterizing the molecular function of YGL041C-B?

When designing experiments to characterize YGL041C-B, implement the following essential controls:

Control TypeImplementationPurpose
Negative ControlIsogenic strain with YGL041C-B deletionEstablish baseline phenotype in absence of protein
Positive ControlKnown protein with similar predicted domainsValidate experimental system functionality
Specificity ControlYGL041C-B with point mutations in predicted active sitesDistinguish specific functional regions
Expression ControlVarying expression levels of YGL041C-BDetermine dose-dependent effects
Environmental ControlsIdentical growth conditions across experimentsMinimize experimental variability
Technical ControlsMultiple technical replicates and standardized protocolsEnsure reproducibility

Additionally, when analyzing protein-protein interactions, include controls for non-specific binding and auto-activation. For functional complementation experiments, use heterologous expression of potential orthologs from related species to test functional conservation. These controls collectively help distinguish true biological functions from experimental artifacts .

How should I approach experimental design when investigating potential genetic interactions between YGL041C-B and other yeast genes?

To investigate genetic interactions involving YGL041C-B, implement a methodical experimental design:

  • Primary screening approach:

    • Synthetic genetic array (SGA) analysis crossing YGL041C-B deletion with yeast deletion collection

    • Quantify growth rates under various conditions to identify synthetic lethal/sick interactions

    • Apply statistical thresholds for interaction strength (e.g., ε < -0.25 for negative interactions)

  • Validation experiments:

    • Tetrad dissection for selected interactions to confirm SGA results

    • Plasmid-based complementation tests to verify specificity

    • Growth curve analysis with increased replication for quantitative interaction measurements

  • Functional characterization of interactions:

    • Group interacting genes by functional categories and cellular processes

    • Perform pathway enrichment analysis to identify overrepresented processes

    • Analyze interaction patterns under different stress conditions

  • Network integration:

    • Construct genetic interaction networks and identify interaction modules

    • Compare with physical interaction data to distinguish direct vs. indirect relationships

    • Apply Bayesian analysis to predict functional relationships

This approach ensures systematic discovery of genetic interactions while minimizing false positives through appropriate validation steps and statistical rigor .

What statistical approaches are most appropriate for analyzing high-throughput data related to YGL041C-B expression and interactions?

When analyzing high-throughput data for YGL041C-B, select statistical approaches based on experimental design and data characteristics:

For differential expression analysis:

  • Apply limma or DESeq2 for RNA-seq data with appropriate modeling of technical and biological variation

  • Implement multiple testing correction (Benjamini-Hochberg) with FDR < 0.05

  • Perform power analysis to ensure sufficient sample size (typically n ≥ 3 biological replicates)

For protein interaction networks:

  • Use SAINT or CompPASS scoring for mass spectrometry interaction data

  • Apply topological analysis methods to identify network clusters

  • Implement permutation tests to establish significance thresholds for interactions

For phenotypic screens:

  • Apply linear mixed-effects models to account for batch effects and technical variation

  • Establish Z-score thresholds (typically |Z| > 2.5) for hit selection

  • Use LOESS normalization for position effects on plates/arrays

Importantly, integrate statistical approaches with biological knowledge to interpret results in context. For example, weak but consistent effects across multiple experimental approaches may have greater biological significance than strong but isolated findings .

How can I determine if observed phenotypes in YGL041C-B mutant strains are directly attributable to the protein's function?

To establish causality between YGL041C-B and observed phenotypes, implement a comprehensive validation strategy:

  • Genetic rescue experiments:

    • Reintroduce wild-type YGL041C-B under native or controllable promoter

    • Quantify restoration of wild-type phenotype with statistical analysis

    • Test rescue with orthologous genes from related species

  • Domain analysis:

    • Create targeted mutations in predicted functional domains

    • Test if specific mutations recapitulate full deletion phenotype

    • Perform structure-function analysis with truncated variants

  • Temporal control experiments:

    • Implement conditional expression systems (e.g., tetracycline-responsive promoters)

    • Monitor phenotype dynamics following protein induction/repression

    • Correlate protein activity timelines with phenotypic changes

  • Dosage sensitivity tests:

    • Analyze phenotypes under conditions of protein overexpression

    • Test for dose-dependent relationships between expression level and phenotype strength

    • Identify threshold effects indicating regulatory relationships

  • Specificity controls:

    • Delete/mutate genes with similar predicted functions

    • Compare phenotypic profiles across multiple mutants

    • Identify unique vs. shared phenotypic signatures

These approaches collectively strengthen causal inferences by demonstrating specificity, reversibility, and direct relationships between YGL041C-B and observed phenotypes .

What are the optimal approaches for structural characterization of YGL041C-B as an uncharacterized protein?

For structural characterization of YGL041C-B, employ a tiered methodological approach:

  • Computational structure prediction:

    • Apply AlphaFold2 or RoseTTAFold for initial structure prediction

    • Validate predictions through multiple algorithms and confidence metrics

    • Identify potential functional domains through structural homology

  • Experimental structure determination:

    • Express and purify recombinant protein with optimization of:

      • Expression systems (bacterial, yeast, insect cells)

      • Solubility tags (MBP, SUMO, GST)

      • Buffer conditions for stability

    • Apply appropriate structural determination methods based on protein properties:

MethodApplicationResolutionAdvantagesLimitations
X-ray CrystallographyCrystallizable proteins1-3 ÅAtomic resolutionRequires crystallization
Cryo-EMLarger proteins/complexes2-5 ÅNo crystallization neededSize limitations
NMR SpectroscopySmaller proteins (<30 kDa)AtomicSolution dynamicsSize constraints
Small-angle X-ray ScatteringAny soluble protein10-30 ÅLow concentration neededLow resolution
  • Functional validation of structural features:

    • Perform site-directed mutagenesis of predicted active sites

    • Analyze conservation patterns in structural context

    • Test ligand binding predictions through biophysical methods

This integrated approach provides complementary structural information at different resolution levels, increasing confidence in structural models and functional predictions .

How can I effectively apply CRISPR-Cas9 technology to study YGL041C-B function in S. cerevisiae?

To effectively apply CRISPR-Cas9 for studying YGL041C-B function:

  • Experimental design considerations:

    • Select appropriate promoters for Cas9 expression (constitutive vs. inducible)

    • Design sgRNAs with high on-target and low off-target scores

    • Choose optimal PAM sites considering the GC-rich nature of many yeast genes

  • Implementation strategies:

    • For knockout studies: Design sgRNAs targeting early coding regions

    • For tagging: Target C-terminus with repair templates containing fluorescent tags

    • For base editing: Use Cas9 nickase fused to deaminase for precise mutations

  • Delivery optimization:

    • Transform ribonucleoprotein complexes for transient expression

    • Use plasmid-based systems with appropriate selection markers

    • Optimize transformation conditions for high editing efficiency

  • Validation protocols:

    • Perform targeted sequencing to confirm edits

    • Screen multiple colonies to identify successful transformants

    • Check for off-target effects at predicted sites

  • Advanced applications:

    • Implement CRISPRi for tunable repression by targeting promoter regions

    • Apply CRISPRa for activation studies by fusing dCas9 with activators

    • Develop multiplexed systems to study genetic interactions

This systematic approach ensures efficient genome editing while minimizing off-target effects and maximizing experimental reproducibility .

How can I design collaborative projects to comprehensively characterize YGL041C-B function across multiple research groups?

Designing effective collaborative projects for YGL041C-B characterization requires structured methodology:

  • Establish a collaborative framework:

    • Define clear research questions and hypotheses

    • Divide work based on technical expertise and resources

    • Implement standardized protocols and reporting templates

    • Establish regular communication channels and data sharing platforms

  • Distribute complementary methodological approaches:

    • Assign different omics approaches to specialized laboratories

    • Allocate computational and wet-lab work to appropriate teams

    • Implement cross-validation studies between groups

  • Project management structure:

    • Create a central data repository with version control

    • Establish quality control metrics for data acceptance

    • Define authorship criteria and publication strategy in advance

  • Implementation timeline:

    • Phase 1: Initial characterization (3-6 months)

    • Phase 2: Functional validation (6-12 months)

    • Phase 3: Integration and advanced studies (12-18 months)

  • Resource optimization:

    • Share strain collections and reagents to ensure consistency

    • Implement centralized data analysis pipelines

    • Coordinate access to specialized equipment

This structured approach ensures comprehensive characterization while leveraging diverse expertise and minimizing redundant efforts .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.